Physician profile
Andrew James Bloom
NPI 1750919957
$14,367.78
in general payments reported to CMS, 2019-2025
33 companies · $6,206 in 2025
The $6,206 reported for 2025 was more than what 97% of Primary Podiatric Medicine providers received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $2,764 · 2024: $5,398 · 2025: $6,206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Consulting Fee: $1,200 · Travel and Lodging: $784 · Gift: $19.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,364.52 |
| Consulting Fee | $1,200.00 |
| Travel and Lodging | $784.00 |
| Gift | $19.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $6,282.48 | 2023-2025 | Citrefix, Infinity Adaptis, Prostep |
| Integra Lifesciences Corporation | $2,417.45 | 2023-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Royal Biologics, INC. | $1,200.00 | 2024-2025 | Fibrinet |
| Kerecis Limited | $706.19 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Smith+Nephew, INC. | $653.73 | 2024-2025 | Grafix Pl, Stravix Pl, Renasys Touch |
| Treace Medical Concepts, INC. | $455.26 | 2023-2025 | |
| Tactile Systems Technology INC | $289.53 | 2023-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Abbvie INC. | $221.23 | 2023-2025 | Dalvance, Teflaro |
| Seapearl East, INC | $209.50 | 2023-2025 | |
| Paratek Pharmaceuticals, INC. | $208.58 | 2025 | Nuzyra |
| Convatec INC. | $199.97 | 2024 | |
| Paragon 28, INC. | $189.53 | 2023-2024 | Grappler, Phantom Metatarsal Shortening, Ttc Nail |
| Amgen INC. | $166.86 | 2024-2025 | Krystexxa |
| Extremity Medical | $146.88 | 2025 | |
| Biocomposites INC | $143.18 | 2025 | Stimulan |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Guard Medical INC. | $142.30 | 2024 | Npseal Large |
| Medtronic, INC. | $138.75 | 2024 | Heli-Fx Endoanchor System |
| Musculoskeletal Transplant Foundation INC. | $96.58 | 2023-2025 | |
| Lemaitre Vascular, INC. | $88.85 | 2025 | Artegraft Vascular Graft |
| Orthofix Medical, INC. | $54.31 | 2024-2025 | Physio-Stim |
| Curonix LLC | $49.56 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Kowa Pharmaceuticals America, INC. | $44.18 | 2023 | Seglentis |
| Averitas Pharma INC. | $35.51 | 2025 | Qutenza |
| Ani Pharmaceuticals, INC. | $33.41 | 2025 | Oxistat |
| Hydrofera LLC | $31.65 | 2023 | Hydrofera Blue |
| Cumberland Pharmaceuticals, INC. | $28.82 | 2024 | Vibativ |
| Dynasplint Systems INC. | $28.10 | 2025 | Dynasplint |
| Next Science LLC | $22.64 | 2023 | Blastx, Surgx, Xperience |
| Depuy Synthes Sales INC. | $20.32 | 2025 | Motoband |
| Globus Medical, INC. | $17.39 | 2025 | Senza |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $16.55 | 2025 | Jublia |
| Novo Nordisk INC | $15.74 | 2025 | Wegovy |
| Ibsa Pharma INC. | $12.75 | 2023 | Tirosint, Licart |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Bloom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.